TINGL EXFOLIATING PADS

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TINGL EXFOLIATING PADS
Generic name: SALICYLIC ACID
Manufacturer: Drmtlgy, LLC
Product type: HUMAN OTC DRUG
SPL set ID: d81da185-69e0-41cf-850f-46a207aad0d6
SPL ID: 249a060e-d766-45ca-9173-6aa8117b764a
Version: 1
Effective date: 2025-04-08
Source export date: 2026-11-06
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/5731a8c92e1c0dd2a09d2f92b410e7a70ea29cbf6b8040a6a05e4be5b7c51f0d/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:44:30

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		TINGL EXFOLIATING PADS	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Drmtlgy, LLC	openfda.manufacturer_name
ndc	package	83286-011-01	openfda.package_ndc
ndc	product	83286-011	openfda.product_ndc
ndc11	package	83286001101	derived:openfda.package_ndc
rxcui		797892	openfda.rxcui
spl id		249a060e-d766-45ca-9173-6aa8117b764a	id
spl set id		d81da185-69e0-41cf-850f-46a207aad0d6	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time • avoid contact with eyes, lips and mouth. If contact occurs, flush thoroughly with water Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.